Kwangdong Phar (009290) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.041x

Based on the latest financial reports, Kwangdong Phar (009290) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩26.03 Billion ≈ $17.64 Million USD) by net assets (₩632.20 Billion ≈ $428.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kwangdong Phar - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Kwangdong Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 009290 total debt and obligations for a breakdown of total debt and financial obligations.

Kwangdong Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kwangdong Phar ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Somany Ceramics Limited
NSE:SOMANYCERA
0.119x
Argo Pantes Tbk
JK:ARGO
0.149x
Grupo Minsa S.A.B. de C.V
MX:MINSAB
0.009x
Hanyang Digitech Co. Ltd
KQ:078350
0.008x
Niu Technologies
F:0O9
N/A
Tonghua Grape Wine Co Ltd
SHG:600365
-0.411x
PERPETUAL EQU. INV.
F:P82
N/A
Great China Metal Industry Co Ltd
TW:9905
0.023x

Annual Cash Flow Conversion Efficiency for Kwangdong Phar (2011–2024)

The table below shows the annual cash flow conversion efficiency of Kwangdong Phar from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 009290 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩618.27 Billion
≈ $418.99 Million
₩-12.15 Billion
≈ $-8.24 Million
-0.020x +1.46%
2023-12-31 ₩588.05 Billion
≈ $398.51 Million
₩-11.73 Billion
≈ $-7.95 Million
-0.020x -117.37%
2022-12-31 ₩547.05 Billion
≈ $370.73 Million
₩62.82 Billion
≈ $42.57 Million
0.115x +10.21%
2021-12-31 ₩527.24 Billion
≈ $357.31 Million
₩54.94 Billion
≈ $37.23 Million
0.104x +129.22%
2020-12-31 ₩502.18 Billion
≈ $340.32 Million
₩22.83 Billion
≈ $15.47 Million
0.045x -30.54%
2019-12-31 ₩447.46 Billion
≈ $303.24 Million
₩29.29 Billion
≈ $19.85 Million
0.065x -46.89%
2018-12-31 ₩430.84 Billion
≈ $291.97 Million
₩53.10 Billion
≈ $35.98 Million
0.123x +118.65%
2017-12-31 ₩416.30 Billion
≈ $282.12 Million
₩23.46 Billion
≈ $15.90 Million
0.056x -21.78%
2016-12-31 ₩399.68 Billion
≈ $270.86 Million
₩28.80 Billion
≈ $19.52 Million
0.072x -33.84%
2015-12-31 ₩377.73 Billion
≈ $255.98 Million
₩41.14 Billion
≈ $27.88 Million
0.109x +4.55%
2014-12-31 ₩314.40 Billion
≈ $213.06 Million
₩32.75 Billion
≈ $22.19 Million
0.104x -11.92%
2013-12-31 ₩290.82 Billion
≈ $197.09 Million
₩34.39 Billion
≈ $23.31 Million
0.118x +33.16%
2012-12-31 ₩267.27 Billion
≈ $181.13 Million
₩23.74 Billion
≈ $16.09 Million
0.089x -19.93%
2011-12-31 ₩249.52 Billion
≈ $169.09 Million
₩27.68 Billion
≈ $18.76 Million
0.111x --

About Kwangdong Phar

KO:009290 Korea Packaged Foods
Market Cap
$205.46 Million
₩303.17 Billion KRW
Market Cap Rank
#16442 Global
#687 in Korea
Share Price
₩8270.00
Change (1 day)
-2.71%
52-Week Range
₩5390.00 - ₩11080.00
All Time High
₩11611.32
About

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of ophthalmic, mineral preparations, nutritious tonics, antipyretic, analgesic, anti inflammatory agents, circulating system, and vitamins; and ETC drugs in the areas of anti-malignant-tumor agent, obesity drug, appetite suppressant, antipyretic, analgesic, anti… Read more